Last week about 150 patients receiving chemotherapy at Fox Chase Cancer Center got a little extra comfort to go with their care. Herk’s Heroes, an advocacy group led by Fox Chase nurse navigator Caryn Vadseth spent several hours distributing Chemo Com...
Read More about Herk’s Heroes Bring Comfort to Patients on Chemotherapy
Elizabeth R. Plimack, MD, MS, of Fox Chase Cancer Center in Philadelphia, chaired a session on bladder cancer at the 2017 Genitourinary Cancers Symposium, held February 16–18, 2017, in Orlando, Florida. The session focused on optimizing outcomes ...
Read More about Highlights of the 2017 Genitourinary Cancers Symposium
Dr. Henry Fung and his Fox Chase colleagues present a Continuing Medical Education event on developments in Aggressive Lymphoma; Myelodysplasia; Plasma Cell Dyscrasia; Acute Leukemia and Myeloproliferative Disease; Less Common Lymphomas; Consultative Hemato...
Read More about April 2nd: New Directions in the Diagnosis & Treatment of Hematologic Cancers
If the lymphoma comes back (relapses) after having received a stem cell transplant, treatment options are very limited. Treatment of a post-transplant relapse is further complicated by residual side effects related to the transplant. In the world of bone...
Read More about Post-transplantation Relapse in Lymphomas
The acronym HIPEC stands for hyperthermic intraperitoneal chemotherapy. This procedure is a novel method of delivering chemotherapy in the operating room during surgery for the treatment of advanced cancers that have spread to the lining o...
Read More about A New Procedure Called HIPEC Offers New Treatment Options for Cancer PatientsDr. Patricia Kropf and Dr. Jean-Pierre Issa, a researcher at Fox Chase, are testing the next generation of epigenetic therapy, using genes to fight cancer. It’s being funded by Stand Up To Cancer. Stephanie Stahl and CBSPhilly filed a report on the benefits...
Read More about Epigenetic Therapy Tests at Fox Chase
